Background. A randomized trial was launched in Côte d'Ivoire in 2002 to compare
continuous antiretroviral treatment (hereafter,“C-ART”) to an ART regimen of 2 months off …

Background: The South African national antiretroviral therapy roll-out program is entering its
sixth year, with over 570,000 adults accessing treatment. HIV-1 drug resistance is a potential …

Background: Since 2001, anti-retroviral therapy (ART) has been provided to over 75,000 HIV-
infected patients at the USAID-Academic Model Providing Access to Healthcare (AMPATH) …

HIV-1 drug resistance represents a major obstacle to infection and disease control. This
retrospective study analyzes trends and determinants of resistance in antiretroviral treatment …

TDR is on the rise after the recent scale-up of ART in Africa. To prevent the development and
spread of drug resistance and sustain the effectiveness of ART programmes, there is a need …

Introduction As antiretroviral treatment (ART) continues to expand in resource‐limited
countries, the emergence of HIV drug resistance mutations (DRMs) is challenging in these …

Background. The efficacy of various antiretroviral (ARV) therapy regimens for human
immunodeficiency virus type 2 (HIV-2) infection remains unclear. HIV-2 is intrinsically …

Objectives: To evaluate the frequency and progression over time of the WHO-defined
transmitted HIV-1 drug resistance mutations (DRMs) among antiretroviral treatment (ART) …

Background This study aimed to evaluate HIV type-1 (HIV-1) drug resistance pretreatment
and in those failing first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based …

Background Virological response to antiretroviral treatment (ART) in rural Africa is poorly
described. We examined virological efficacy and emergence of drug resistance in adults …